GLP-1 microdosers are chasing longevity

More than 10 percent of U.S. adults take GLP-1 drugs. But not all of them are taking full doses. Around one in seven users has “microdosed” injections, a recent survey by the health tracking app Evidation found. Some take tiny…

Continue Reading


News Source: www.sciencenews.org

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *